Form 4: Bicycle Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Michael Charles Ferguson Hannay, CHIEF PROD & SUPPLY CHAIN OFF of Bicycle Therapeutics Plc, received 60,000 shares of common stock on July 15, 2026.
Summary
- Grant/award: acquired 60,000 Employee Stock Option (right to buy) on July 15, 2026; holds 60,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael Charles Ferguson Hannay — Officer (CHIEF PROD & SUPPLY CHAIN OFF)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Employee Stock Option (right to buy) | 60,000 | — | — | 60,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (60,000 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, neutral, Michael Charles Ferguson Hannay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.